<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined the effect of <z:chebi fb="0" ids="49005">deferasirox</z:chebi> (DFX) on CD34+ hematopoietic progenitors from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="1" pm="."><plain>Progressive, dose-dependent suppression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> progenitor proliferation in culture was observed with DFX concentrations ranging from 5 μM to 20 μM </plain></SENT>
<SENT sid="2" pm="."><plain>This effect was more pronounced in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> compared to CD34+ progenitors isolated from umbilical cord blood or <z:mpath ids='MPATH_458'>normal</z:mpath> peripheral blood </plain></SENT>
<SENT sid="3" pm="."><plain>There was <z:mp ids='MP_0010831'>reduced viability</z:mp> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> progenitors but not <z:mpath ids='MPATH_458'>normal</z:mpath> progenitors at 20 μM DFX which increased with duration of exposure </plain></SENT>
<SENT sid="4" pm="."><plain>Exposure to 20 μM DFX for 14 days markedly suppressed colony growth of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> progenitors </plain></SENT>
<SENT sid="5" pm="."><plain>Reactive oxygen species levels were elevated above control at concentrations of DFX above 5 μM </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that exposure to DFX results in dose-dependent inhibition of proliferation, and survival in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> progenitors </plain></SENT>
</text></document>